Abstract

PurposePatients with cancer of the lower and middle rectum who are candidates for curative surgery often have negative opinions on definitive colostomy. The purpose of this study is to compare the quality of life (QoL) of patients who undergo standard treatment for rectal cancer with sphincter preservation or definitive colostomy.MethodsA total of 125 patients with adenocarcinoma of the lower or middle rectum who underwent radical surgery with curative intent with a follow-up ≥ 1 year were recruited: 83 patients (group 1) were subjected to low anterior resection and low colorectal or coloanal anastomosis—thus preserving their sphincter—and 42 (group 2) were treated with abdominoperineal resection, followed by terminal definitive colostomy. QoL was assessed with the EORTC QLQ-C30 and QLQ-CR29 questionnaires.ResultsHealth and global quality of life were similar between groups; however, patients who underwent definitive colostomy had higher scores on the emotional (p value = 0.016) and cognitive function scales (p value = 0.017). Patients with sphincter preservation presented with more symptoms that were related to stool frequency (p value < 0.001), intestinal constipation (p value = 0.005), fecal incontinence (p value = 0.001), buttock pain (p value = 0.023), and nausea and vomiting (p value = 0.036), whereas patients with permanent colostomy had higher scores for dysuria (p value = 0.033).ConclusionAlthough global QoL scores did not differ between groups, patients who underwent definitive colostomy had significantly better functional and symptom scale scores, reflecting greater function with fewer symptoms.

Highlights

  • The incidence of colorectal cancer (CRC) has risen gradually in the past several decades

  • The patients were divided into two groups: (1) the sphincter preservation group (SPG) contained 83 patients (66%) who were subjected to low anterior resection of the rectum (LAR) and low colorectal or coloanal anastomosis and anatomic sphincter preservation; and (2) the definitive colostomy group (DCG) was composed of 42 patients (34%) who underwent abdominoperineal resection (APR) and terminal definitive colostomy

  • The DCG had a higher proportion of lower rectal tumors (78.6 vs. 41.0%; p value < 0.001) and received pelvic radiotherapy more frequently (92.7 vs. 75.3%; p value = 0.015) than SPG patients

Read more

Summary

Introduction

The incidence of colorectal cancer (CRC) has risen gradually in the past several decades. CRC ranks third highest in incidence among noncommunicable diseases and is the fourth leading cause of mortality worldwide [1, 2]. Neoadjuvant chemoradiation of patients with locally advanced lower and middle rectal tumors (cT3/T4 or N+) reduce local recurrence rates and contribute to sphincter preservation (SP) [4]. There is interest in developing more conservative therapies that focus on selecting patients for treatments that are based exclusively on chemoradiation [5, 6]. Despite our knowledge of the outcomes of conservative treatment protocols, surgery with total mesorectal excision (TME) and adequate margins continues to be the most important component of a curative treatment strategy

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call